If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRegional Reit Regulatory News (RGL)

Share Price Information for Regional Reit (RGL)

Share Price is delayed by 15 minutes
Get Live Data
95.00    0.40 (0.42%)
Bid:
93.80
Ask:
94.30
Spread: 0.50 (0.533%)
Market Cap: £153.98m
RGL Live PriceLast checked at - London Stock Exchange

Intraday Regional Reit Share Chart

Director/PDMR Shareholding

18 Feb 2016 13:15

RNS Number : 4941P
Regional REIT Limited
18 February 2016
Β 

Annex DTR3

Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons

Β 

In accordance with the requirements of DTR 3.1.4R, Regional REIT Limited (the "Company") wishes to notify the following changes in the interests in ordinary shares of no par value in the Company

Β 

Β 

1.

Name of the issuer

2.

State whether the notification relates to (i) a transaction notified in accordance with DTR 3.1.2 R, (ii) a disclosure made in accordance with section 793 of the Companies Act 2006, or (iii) in accordance with paragraph 26 of the Model Code

Regional REIT Limited

DTR 3.1.2 R

3.

Name of persons discharging managerial responsibilities/director

4.

State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person

Derek Porter

Ronald Barrie Clapham

Douglas Cumine

Stephen Inglis

Dr Frank Blin

Derek McDonald

Β 

N/A

5.

Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest'

6.

Description of shares (including class), debentures or derivatives or financial instruments relating to shares

In respect of the persons in (3) above

Ordinary shares of no par value

7.

Name of registered shareholders(s) and, if more than one, the number of shares held by each of them

8

State the nature of the transaction

TCP Founder Partner Limited

Distribution of shares in Regional REIT Limited to each of the individuals in (3) above.

9.

Number of shares, debentures or financial instruments relating to shares acquired

10.

Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)

Derek Porter - 608,320

Ronald Barrie Clapham - 2,999,015

Douglas Cumine - 273,743

Stephen Inglis - 1,502,549

Dr Frank Blin - 304,159

Derek McDonald - 395,407

Β 

Derek Porter - 0.2%

Ronald Barrie Clapham - 1.1%

Douglas Cumine - 0.09%

Stephen Inglis - 0.5%

Dr Frank Blin - 0.1%

Derek McDonald - 0.1%

Β 

11.

Number of shares, debentures or financial instruments relating to shares disposed

12.

Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)

N/A

Β 

N/A

13.

Price per share or value of transaction

14.

Date and place of transaction

nil

18 February 2016

Β UK

15.

Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)

16.

Date issuer informed of transaction

HOLDING

Β 

Derek Porter - 608,320 (0.2%)

Ronald Barrie Clapham - 3,649,600 (1.3%)

Douglas Cumine - 309,378 (0.1%)

Stephen Inglis - 1,502,549 (0.5%)

Dr Frank Blin - 304,159 (0.1%)

Derek McDonald - 395,407 (0.1%)

18 February 2016

Β 

Β 

If a person discharging managerial responsibilities has been granted options by the issuer complete the following boxes

17

Date of grant

18.

Period during which or date on which exercisable

19.

Total amount paid (if any) for grant of the option

20.

Description of shares or debentures involved (class and number)

21.

Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise

22.

Total number of shares or debentures over which options held following notification

23.

Any additional information

24.

Name of contact and telephone number for queries

The PDMRs have entered into lock-in agreements in respect of the shares the subject of this notification on substantially the same terms as the lock-in agreement entered into by TCP Founder Partner on IPO

Martin McKay - 020 7845 6100

Β 

Name of authorised officer of issuer responsible for making notification

Β 

Martin McKay

Date of notification

18 February 2016

Β 

This form is intended for use by an issuer to make a RIS notification required by DR 3.1.4R(1).

(1) An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.

(2) An issuer making a notification in respect of a derivative relating the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24.

(3) An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.

(4) An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
RDSSFDFDAFMSEFE
Date   Source Headline
22nd Jul 20245:07 pmRNSDirector/PDMR Shareholding
19th Jul 20243:44 pmRNSNotice of AGM
18th Jul 20242:24 pmRNSResult of EGM
28th Jun 20243:21 pmRNSDirector/PDMR Shareholding
27th Jun 202411:00 amRNSPublication of Prospectus
27th Jun 20247:00 amRNSUnderwritten £110.5m Capital Raise & Notice of EGM
22nd May 20247:00 amRNSQ1 2024 Trading Update, Dividend and EPC Update
1st May 20247:00 amRNSPositive Letting Update
22nd Apr 20245:36 pmRNSHolding(s) in Company
16th Apr 20247:00 amRNSPositive Letting Update
26th Mar 20247:00 amRNS2023 Full Year Results
12th Mar 20247:00 amRNSResponse to Press Speculation
22nd Feb 20247:00 amRNSDividend Declaration
2nd Feb 20247:00 amRNSQ4 23 Valuation and Portfolio Update
9th Nov 20237:00 amRNSQ3 23 Trading Update, Dividend and ESG Update
9th Nov 20237:00 amRNSOffice Sale 26.3% above Valuation
31st Oct 20237:00 amRNSNorfolk House – Positive Letting Update
12th Oct 202312:29 pmRNSDirector/PDMR Shareholding
11th Oct 20237:00 amRNSAppointment of ARA Europe as Investment Adviser
3rd Oct 20237:15 amEQSRegional REIT: Dividend rebase pragmatic and sustainable
12th Sep 20237:00 amRNSQ2 2023 Dividend Declaration
12th Sep 20237:00 amRNS2023 Half Year Results
11th Aug 202311:34 amRNSReplacement - Released in Error
11th Aug 20237:00 amRNSEdison issues update on Target Healthcare REIT
9th Jun 20237:00 amRNSUpdate on Office Occupancy
25th May 20233:14 pmRNSResult of AGM
24th May 20237:00 amRNSTrading Update and Dividend Declaration
14th Apr 20234:00 pmRNSQuotedData's Weekly News & Interview
13th Apr 20237:00 amRNSAsset Manager Update
30th Mar 20239:30 amRNSAsset Manager Update
28th Mar 20237:00 amRNSFinal Results
23rd Feb 20237:00 amRNSQ4 22 Divi, Letting Update & FY22 Valuation
14th Feb 20237:00 amRNSPositive Update on Office Use
13th Dec 20227:00 amRNSPositive Lettings Update
11th Nov 202210:05 amRNSDirector/PDMR Shareholding
10th Nov 20227:00 amRNSQ3 2022 Trading Update and Dividend Declaration
20th Oct 20224:13 pmRNSDirector/PDMR Shareholding
15th Sep 20227:00 amRNSHalf-year Report
24th Aug 20227:00 amRNSDividend Declaration
15th Aug 20225:03 pmRNSDirector/PDMR Shareholding
15th Aug 20225:01 pmRNSDirector/PDMR Shareholding
15th Aug 20224:58 pmRNSDirector/PDMR Shareholding
15th Aug 202211:58 amRNSDirector/PDMR Shareholding
12th Aug 20224:45 pmRNSDirector/PDMR Shareholding
12th Aug 20224:44 pmRNSDirector/PDMR Shareholding
12th Aug 20224:42 pmRNSDirector/PDMR Shareholding
12th Aug 20224:41 pmRNSDirector/PDMR Shareholding
7th Jul 202212:01 pmRNSDirector/PDMR Shareholding
7th Jul 202211:35 amRNSDirector/PDMR Shareholding
7th Jul 202211:35 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.